In a remarkable case, the administration of AMPC on patients with acute myeloid leukaemia (AML)–a debilitating blood disorder—has elicited a recovery in normal white blood cell counts after chemotherapy. This holds tremendous potential for establishing AMPC as a possible option for AML treatments. Currently, the most effective treatments for AML involve a combination of chemotherapy … Continue reading AML Trial